← Back to Search

HOME Program for Traumatic Brain Injury (HOME Trial)

N/A
Recruiting
Led By Laraine Winter, PhD
Research Sponsored by Villanova University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
TBI Participant must meet criteria for mild, moderate, or severe TBI
TBI Participant must be English speaking
Must not have
TBI Participant with history of recent violence
TBI Participant with aphasia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four months and ten months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a home-based therapy program called HOME for people with long-term TBI symptoms and their families. Therapists visit homes to help adjust the living environment and teach coping strategies. The goal is to improve patients' quality of life and reduce caregiver stress.

Who is the study for?
This trial is for individuals with chronic symptoms from a traumatic brain injury (TBI) that occurred over a year ago, and their family members who live with them and are actively involved in their lives. Participants must be adults who speak English and can consent to the study. It's not for those with dementia, recent violence or psychosis, or difficulty understanding interview questions.
What is being tested?
The HOME Program is being tested; it's an at-home occupational therapy intervention designed to help TBI patients manage symptoms and improve quality of life. Over four months, therapists work with patients and families on strategies tailored to individual needs within the home environment.
What are the potential side effects?
Since this intervention involves non-medical therapeutic activities focused on rehabilitation rather than drugs or surgery, traditional side effects are not expected. However, there may be emotional or psychological impacts as participants adjust to new routines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a traumatic brain injury classified as mild, moderate, or severe.
Select...
I speak English.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of recent violence and have experienced a traumatic brain injury.
Select...
I have difficulty speaking or understanding language due to a brain injury.
Select...
I have experienced psychosis recently after a brain injury.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four months and ten months
This trial's timeline: 3 weeks for screening, Varies for treatment, and four months and ten months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Caregiver burden scores on the Caregiver Burden subscale of the Caregiver Assessment Scale (CAS) for the family member
Community reintegration (CR) scores on PART-O-17 for the person with TBI
Depressive symptom scores on the CES-D for the family member
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HOME for UsExperimental Treatment1 Intervention
The HOME intervention is the delivery of an in-home, family inclusive, rehabilitation intervention in eight sessions. Six of the sessions will occur in the home, and two will be over the phone. The in-home sessions will be about 1 ½ hrs. each, and the phone sessions will be about 15 minutes each. The sessions are delivered by an occupational therapist (OT).
Group II: Attention ControlActive Control1 Intervention
The Attention-control condition is the delivery of educational materials over 8 contacts. Three of the contacts are by video conferences or phone calls and last 1 to 2 hours each. Two of the contacts are mailings of educational materials for discussion during the longer sessions. Three of the contacts are phone calls lasting about 10-15 minutes each to check for general updates, health care utilization/access, and study reminders.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Traumatic Brain Injury (TBI) often involve a combination of occupational therapy, physical therapy, and cognitive rehabilitation. These therapies work by realigning environmental demands to match the individual's strengths and deficits, thereby helping to manage chronic TBI symptoms. For instance, occupational therapy focuses on improving the patient's ability to perform daily activities by modifying the home environment and teaching adaptive strategies. Physical therapy aims to enhance mobility and physical function, while cognitive rehabilitation targets the improvement of cognitive skills such as memory and attention. These interventions are crucial for TBI patients as they promote independence, improve quality of life, and facilitate better community reintegration.
Randomized Controlled Trials of Rehabilitation Services in the Post-acute Phase of Moderate and Severe Traumatic Brain Injury - A Systematic Review.Critical appraisal of systematic reviews of executive function treatments in TBI.

Find a Location

Who is running the clinical trial?

Villanova UniversityLead Sponsor
7 Previous Clinical Trials
2,781 Total Patients Enrolled
Drexel UniversityOTHER
155 Previous Clinical Trials
47,782 Total Patients Enrolled
Thomas Jefferson UniversityOTHER
463 Previous Clinical Trials
175,284 Total Patients Enrolled

Media Library

HOME for Us Clinical Trial Eligibility Overview. Trial Name: NCT05117619 — N/A
Traumatic Brain Injury Research Study Groups: HOME for Us, Attention Control
Traumatic Brain Injury Clinical Trial 2023: HOME for Us Highlights & Side Effects. Trial Name: NCT05117619 — N/A
HOME for Us 2023 Treatment Timeline for Medical Study. Trial Name: NCT05117619 — N/A
~112 spots leftby Nov 2025